Cite
HARVARD Citation
Ruperto, N. et al. (2013). OP0136 Baseline Characteristics of Patients with Active Systemic JIA Successfully Discontinuing Corticosteroid while Receiving Canakinumab: Secondary Analysis from a Pivotal Phase 3 Trial. Annals of the rheumatic diseases. pp. A97-A98. [Online].